Koyfin Home > Directory > Health Care > Intercept Pharmaceuticals > Price / Sales (ntm)

Intercept Pharmaceuticals Price / Sales (ntm) Chart (ICPT)

Intercept Pharmaceuticals annual/quarterly Price / Sales (ntm) from 2012 to 2020.
  • Intercept Pharmaceuticals Price / Sales (ntm) for the quarter ending October 10, 2020 was 2.98 a -14.10% decrease of -0.42 year over year
  • Intercept Pharmaceuticals Price / Sales (ntm) for the last 12 months ending October 10, 2020 was 2.98 a -14.10% decrease of -0.42 year over year
  • Intercept Pharmaceuticals Annual Price / Sales (ntm) for 2020 was 2.98 a -6.30% decrease of -0.19 from 2019
  • Intercept Pharmaceuticals Annual Price / Sales (ntm) for 2020 was 3.17 a -7.82% decrease of -0.25 from 2019
  • Intercept Pharmaceuticals Annual Price / Sales (ntm) for 2020 was 3.41 a 0.45% increase of 0.02 from 2019
Other Valuation Metrics:
  • Intercept Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $1,549m a -95.52% decrease of -1,479m year over year
  • Intercept Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 94.51 a 86.66% increase of 81.90 year over year
  • Intercept Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $1,489m a -85.63% decrease of -1,275m year over year
View Chart On Koyfin

Quarterly ICPT Price / Sales (ntm) Data

10/20202.98
10/20203.17
10/20203.41
10/20203.40
10/20203.35
10/20203.42
10/20203.29
10/20203.59
10/20203.68
10/20204.01

Annual ICPT Price / Sales (ntm) Data

20202.98
20203.17
20203.41
20203.40
20203.35
20203.42
20203.29
20203.59
20203.68
20204.01